ROLE OF ENDOTHELIN IN ACUTE LUNG INJURY

内皮素在急性肺损伤中的作用

基本信息

  • 批准号:
    6302257
  • 负责人:
  • 金额:
    $ 17.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-12-01 至 2000-11-30
  • 项目状态:
    已结题

项目摘要

OBJECTIVE: The overall goal of this ongoing project is to investigate the role of endothelin-1 (ET-1) in human lung injury. HYPOTHESES: 1. During dysregulated inflammatory events, we hypothesize that inflammatory mediators, changes in O/2 tension, and alterations in second messengers lead to an increase in ET-1 production and ET receptor expression in human lung cells. 2. We hypothesize that ET-1 produces lung injury by increasing endothelial cell susceptibility to oxidant damage and by enhancing PMN-mediated injury. 3. We hypothesize that increased levels of ET-1 and increased expression of ET receptors promote alveolar inflammation and pulmonary hypertension in patients with ARDS. RESEARCH PLAN: The project will investigate molecular, biochemical and physiologic mechanisms by which the ET system (ET-1 and ET receptors) influences lung injury. The first aim will investigate the molecular and cellular regulation of ET-1 synthesis and ET receptors in human lung endothelial cells, epithelial cells and macrophages in response to inflammatory modulators and physiologic conditions (hypoxia and hyperoxia) present in ARDS patients. These cells have been selected because, in ARDS lungs compared to non-ARDS lungs, these cells have a marked increased in ET-1 immunostaining. The second aim will determine the effect of ET on injury in pulmonary endothelial cells, vascular tissue, the isolated lung and the whole animal. These experiments will test the hypothesis that ET produces injury by increasing endothelial cell susceptibility to oxidant injury and by promoting neutrophil-mediated damage. These experiments will extend our preliminary findings, which indicate that ET promotes injury, and will focus on investigating potential mechanisms. The third aim will compare the level of ET-1 production and ET receptor expression in the lungs of ARDS and at risk patients and assess the relationship between plasma and bronchoalveolar lavage ET-1 levels and pulmonary hypertension, markers of alveolar inflammation and clinical course. This aim will investigate the hypothesis that ET contributes to alveolar inflammation and pulmonary hypertension in ARDS patients. SIGNIFICANCE: The proposed research will substantially improve our understanding of the role of ET-1 in human lung injury and the mechanism by which ET-1 promotes vascular injury and inflammation.
目的:这个正在进行的项目的总体目标是调查 内皮素-1(ET-1)在人肺损伤中的作用 假设:1.在失调的炎症事件中,我们假设 炎症介质、O/2张力的变化以及 第二信使导致ET-1产生和ET受体增加 在人肺细胞中表达。 2.我们推测ET-1通过增加内皮细胞的增殖而引起肺损伤。 细胞对氧化损伤的敏感性,并通过增强PMN介导的 损伤 3.我们假设ET-1水平的增加和表达的增加 ET受体的表达促进肺泡炎症和肺动脉高压 在ARDS患者中。 研究:该项目将研究分子,生物化学和 ET系统(ET-1和ET受体)的生理机制 影响肺损伤。第一个目标是研究分子和 人肺ET-1合成及其受体的细胞调节 内皮细胞、上皮细胞和巨噬细胞响应于 炎症调节剂和生理条件(缺氧和高氧) 存在于ARDS患者中。选择这些细胞是因为, 与非ARDS肺相比,这些细胞在 ET-1免疫染色。第二个目标将确定ET对 肺内皮细胞,血管组织,离体肺损伤 整个动物。这些实验将检验ET 通过增加内皮细胞对氧化剂的敏感性而产生损伤 损伤和促进嗜中性粒细胞介导的损伤。这些实验将 扩展我们的初步发现,这表明ET促进损伤, 并将重点调查潜在的机制。第三个目标将 比较在不同的时间点, 肺的ARDS和危险患者,并评估 血浆和支气管肺泡灌洗ET-1水平和肺动脉高压, 肺泡炎症和临床病程的标志物。这一目标将 研究ET参与肺泡炎症的假说 和肺动脉高压。 意义:拟议的研究将大大提高我们的 ET-1在人肺损伤中的作用及其机制的研究进展 ET-1通过其促进血管损伤和炎症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN R MICHAEL其他文献

JOHN R MICHAEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN R MICHAEL', 18)}}的其他基金

ROLE OF ENDOTHELIN IN ACUTE LUNG INJURY
内皮素在急性肺损伤中的作用
  • 批准号:
    6564917
  • 财政年份:
    2001
  • 资助金额:
    $ 17.12万
  • 项目类别:
ROLE OF ENDOTHELIN IN ACUTE LUNG INJURY
内皮素在急性肺损伤中的作用
  • 批准号:
    6110232
  • 财政年份:
    1998
  • 资助金额:
    $ 17.12万
  • 项目类别:
THE ROLE OF NITRIC OXIDE IN ACUTE LUNG INJURY
一氧化氮在急性肺损伤中的作用
  • 批准号:
    6272946
  • 财政年份:
    1997
  • 资助金额:
    $ 17.12万
  • 项目类别:
THE ROLE OF NITRIC OXIDE IN ACUTE LUNG INJURY
一氧化氮在急性肺损伤中的作用
  • 批准号:
    6242252
  • 财政年份:
    1996
  • 资助金额:
    $ 17.12万
  • 项目类别:
REGULATION OF PULMONARY VASCULAR TONE
肺血管张力的调节
  • 批准号:
    3074421
  • 财政年份:
    1989
  • 资助金额:
    $ 17.12万
  • 项目类别:
REGULATION OF PULMONARY VASCULAR TONE
肺血管张力的调节
  • 批准号:
    3074419
  • 财政年份:
    1989
  • 资助金额:
    $ 17.12万
  • 项目类别:
REGULATION OF PULMONARY VASCULAR TONE
肺血管张力的调节
  • 批准号:
    3074422
  • 财政年份:
    1989
  • 资助金额:
    $ 17.12万
  • 项目类别:
REGULATION OF PULMONARY VASCULAR TONE
肺血管张力的调节
  • 批准号:
    3074423
  • 财政年份:
    1989
  • 资助金额:
    $ 17.12万
  • 项目类别:
REGULATION OF PULMONARY VASCULAR TONE
肺血管张力的调节
  • 批准号:
    3074424
  • 财政年份:
    1989
  • 资助金额:
    $ 17.12万
  • 项目类别:
THE ROLE OF NITRIC OXIDE IN ACUTE LUNG INJURY
一氧化氮在急性肺损伤中的作用
  • 批准号:
    5214057
  • 财政年份:
  • 资助金额:
    $ 17.12万
  • 项目类别:

相似海外基金

The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 17.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
  • 批准号:
    MR/X005046/1
  • 财政年份:
    2023
  • 资助金额:
    $ 17.12万
  • 项目类别:
    Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
  • 批准号:
    23H03154
  • 财政年份:
    2023
  • 资助金额:
    $ 17.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
  • 批准号:
    10607319
  • 财政年份:
    2023
  • 资助金额:
    $ 17.12万
  • 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
  • 批准号:
    471247
  • 财政年份:
    2022
  • 资助金额:
    $ 17.12万
  • 项目类别:
    Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
  • 批准号:
    485971
  • 财政年份:
    2022
  • 资助金额:
    $ 17.12万
  • 项目类别:
    Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
  • 批准号:
    22K06698
  • 财政年份:
    2022
  • 资助金额:
    $ 17.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
  • 批准号:
    462596862
  • 财政年份:
    2021
  • 资助金额:
    $ 17.12万
  • 项目类别:
    WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
  • 批准号:
    21K16251
  • 财政年份:
    2021
  • 资助金额:
    $ 17.12万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
  • 批准号:
    NC/V001019/1
  • 财政年份:
    2021
  • 资助金额:
    $ 17.12万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了